Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2022
October
10
Report of potential Bio-Rad, Qiagen combination generates mixed investor response
Walgreens, Aegis Sciences develop mechanism for early surveillance of emerging variants
New gene target discovered for aggressive small-cell lung cancer subtype
Plexision completes development of rapid blood test for organ transplant rejection risk
Thermo Fisher Scientific launches CE-IVD marked panel to detect most common gastrointestinal bacteria
Gestalt Diagnostics receives CE-IVD marks for cloud-based digital pathology components
Page 1 of 1